Lenvatinib is More Effective & Safer Than Sorafenib in the Treatment of Renal Cell Carcinoma - A Single-Center Retrospective Analysis of 70 Cases. JOC [Internet]. 2024 Dec. 18 [cited 2026 Jan. 16];23(1):624-8. Available from: https://carcinogenesis.com/index.php/JOC/article/view/1770